The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s implantable heart pacemaker market report forecasts the implantable heart pacemaker market size to grow to $5.58 Billion by 2027, with a CAGR (compound annual growth rate) of more than 3%.

Learn More On The Implantable Heart Pacemaker Market Report 2023 – https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Implantable Heart Pacemaker Market Size Forecast
The global implantable heart pacemaker market is expected to grow from $4.66 billion in 2022 to $4.84 billion in 2023 at a compound annual growth rate (CAGR) of 4.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The implantable heart pacemaker market size is expected to grow to $5.58 billion in 2027 at a CAGR of 3.6%.

North America held the largest implantable heart pacemaker market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Implantable Heart Pacemaker Market Driver ­– Increase In The Incidence Of Chronic Diseases
For instance, in 2022, Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people are suffering from diabetes which equals 11.3% of the United States population. Additionally, in December 2021, according to the International Diabetes Federation, a Belgium-based leading global diabetes community, approximately 537 million adults are suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increasing incidence of chronic diseases is driving the growth of implantable heart pacemakers.

Request for A Sample Of The Global Implantable Heart Pacemaker Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8583&type=smp

Key Implantable Heart Pacemaker Market Trend – Technological Advancement
Major companies and research institutes operating in the market are developing innovative implantable heart pacemakers with features such as MRI-conditional models, improved battery life, new pacemaker functionality, wireless and automated monitoring, and others to sustain their position in the market. For instance, in June 2021, the researchers of Northwestern and George Washington University, a US-based nationally chartered private research university developed the first transitory pacemaker. This device is a wireless, battery-free, and totally implanted pacing device that vanishes when no longer required. The thin, flexible, and lightweight device could be utilized in patients who require temporary pacing following cardiac surgery or while awaiting a permanent pacemaker. Using near-field communication protocols technology, the device wirelessly gathers energy from an external, remote antenna. This eliminates the need for heavy batteries as well as stiff hardware such as wires (or leads).

Implantable Heart Pacemaker Market Segment
1) By Product Type: Single Chamber, Dual Chamber, Biventricular
2) By Application: Heart Block, Sick Sinus Syndrome, Diagnosing Heart Diseases, Other Applications
3) By End User: Hospital, Clinics, House Hold, Other End Users

Implantable Heart Pacemaker Market Major Players and Strategies
Major players in the implantable heart pacemaker market are Medtronic plc., Biotronik, Boston Scientific Corporation, Abbott Laboratories, ZOLL Medical Corporation, MEDICO SRL, Vitatron, Shree Pacetronix Ltd., St Jude Medical Inc., Sorin Group, Osypka Medical GmbH, OSCOR lnc., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC., Cook Group Incorporated, CCC Medical Devices, and MicroPort Scientific Corporation.

In November 2022, Johnson & Johnson, a US-based manufacturer of healthcare products and related services acquired Abiomed for a deal of $16.6 billion. The acquisition is expected to propel Johnson & Johnson MedTech’s (JJMT) position as a growing cardiovascular innovation, increasing the standard of care in one of healthcare’s most pressing unmet needs of heart failure and recovery. Abiomed is a US-based company involved in the research, development, and sale of medical devices to assist the functions of the heart.

The Implantable Heart Pacemaker Global Market Report 2023 covers regional data on implantable heart pacemaker market size, implantable heart pacemaker market trends and drivers, opportunities, strategies, and implantable heart pacemaker market competitor analysis. The countries covered in the implantable heart pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A pacemaker refers to a tiny device implanted in the chest for controlling the heartbeat. Its purpose is to keep the heart from beating too slowly.

View More Reports Related To The Implantable Heart Pacemaker Market –
Pacemakers Global Market Report 2023
Cardiovascular Devices Global Market Report 2023
Cardiac Assist Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: